Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Natural Killer Cells”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT03774654
What this trial is testing

CD19.CAR Allogeneic NKT for Patients With Relapsed or Refractory B-Cell Malignancies (ANCHOR)

Who this might be right for
Refractory B-Cell Non-Hodgkin LymphomaRefractory B-Cell Small Lymphocytic LymphomaRelapsed Adult ALL+2 more
Baylor College of Medicine 13
Not applicableStudy completedNCT03630328
What this trial is testing

Angelica Gigas Dietary Supplements and Human Immune Cells

Who this might be right for
Innate Immune Cells
Milton S. Hershey Medical Center 15
Testing effectiveness (Phase 2)UnknownNCT02725996
What this trial is testing

By Using Adoptive Transfer of Autologous NK Cells to Prevent Recurrence of Hepatocellular Carcinoma After Curative Therapy

Who this might be right for
Hepatocellular Carcinoma
Southwest Hospital, China 140
Not applicableStudy completedNCT02794896
What this trial is testing

Anesthetic Depth Effects Upon Immune Competent Cells

Who this might be right for
ImmunotoxicityAnesthesiaInert Gas Narcosis
Heidelberg University 16
Early research (Phase 1)WithdrawnNCT01336478
What this trial is testing

CD56+CD3- NK Cells Following Allogeneic Stem Cell Transplantation

Who this might be right for
Haematological MalignanciesAllogeneic Stem Cell TransplantCD56+CD3- NK Cells
Imperial College London
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05319249
What this trial is testing

Natural Killer Cell Immunotherapy in Combination With PARP-inhibition in Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
German Cancer Research Center 54
Early research (Phase 1)Study completedNCT03899480
What this trial is testing

Adoptive Transfer of Haploidentical NK Cells and N-803

Who this might be right for
HivHIV InfectionsImmune Deficiency
University of Minnesota 9
Testing effectiveness (Phase 2)Enrolling By InvitationNCT01868490
What this trial is testing

The Adoptive Immunotherapy for Solid Tumors Using Modified Autologous CIK Cells

Who this might be right for
CholangiocarcinomaNeuroblastoma
Siriraj Hospital 20
Testing effectiveness (Phase 2)Study completedNCT01729091
What this trial is testing

Umbilical Cord Blood-Derived Natural Killer Cells, Elotuzumab, Lenalidomide, and High Dose Melphalan, Followed by Stem Cell Transplant in Treating Patients With Multiple Myeloma

Who this might be right for
Plasma Cell LeukemiaPlasma Cell Myeloma
M.D. Anderson Cancer Center 72
Early research (Phase 1)Study completedNCT00774358
What this trial is testing

Interleukin-2 Treatment for Wiskott-Aldrich Syndrome

Who this might be right for
Wiskott-Aldrich Syndrome (WAS)X-linked Thrombocytopenia
Soma Jyonouchi 9
Not applicableStudy completedNCT00435864
What this trial is testing

Natural Killer Index From Hematopoietic Stem Cell Graft

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloblastic LeukemiaChronic Myeloid Leukemia
Nantes University Hospital 92
Early research (Phase 1)Study completedNCT01576692
What this trial is testing

Combination Chemotherapy, Monoclonal Antibody, and Natural Killer Cells in Treating Young Patients With Recurrent or Refractory Neuroblastoma

Who this might be right for
Neuroblastoma
St. Jude Children's Research Hospital 34
Not applicableUnknownNCT03955848
What this trial is testing

INFUSION OF ALLOREACTIVE NATURAL KILLER (NK) CELLS AS CONSOLIDATION STRATEGY FOR ACUTE MYELOID LEUKEMIA PATIENTS

Who this might be right for
Adult Acute Myeloid Leukemia in Remission
IRCCS Azienda Ospedaliero-Universitaria di Bologna 80
Testing effectiveness (Phase 2)Study completedNCT00789776
What this trial is testing

Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation, and Donor Bone Marrow Transplant Followed by Donor Natural Killer Cell Therapy, Mycophenolate Mofetil, and Tacrolimus in Treating Patients With Hematologic Cancer

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAggressive Non-Hodgkin Lymphoma+13 more
Fred Hutchinson Cancer Center 41
Testing effectiveness (Phase 2)Study completedNCT00536978
What this trial is testing

Natural Killer (NK) Cell Adback After Allogeneic Stem Cell Transplant With Campath-IH Plus Chemorx for Patients With Lymphoid Malignancies

Who this might be right for
LymphomaLeukemia
M.D. Anderson Cancer Center 22
Testing effectiveness (Phase 2)Ended earlyNCT00871689
What this trial is testing

Chemotherapy, Total-Body Irradiation, Donor Natural Killer Cell Infusion, Aldesleukin, and UCB Transplant in Treating Patients With Relapsed or Refractory AML

Who this might be right for
Leukemia
Masonic Cancer Center, University of Minnesota 2
Testing effectiveness (Phase 2)UnknownNCT03329664
What this trial is testing

Autologous Killer Cell Therapy in Colon Cancer Patients

Who this might be right for
Colon Cancer Stage IV
Sabz Biomedicals 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT02494804
What this trial is testing

Effect of Cytokine-induced Killer Cells for Stage I-II Malignant Gliomas

Who this might be right for
Cytokine-Induced Killer CellsMilignant Gliomas
The First People's Hospital of Changzhou 80
Testing effectiveness (Phase 2)UnknownNCT01520558
What this trial is testing

CNDO-109-AANK for AML in First Complete Remission (CR1)

Who this might be right for
Acute Myeloid Leukemia
Coronado Biosciences, Inc. 12
Early research (Phase 1)Active Not RecruitingNCT06325748
What this trial is testing

SENTI-202: Off-the-shelf Logic Gated CAR NK Cell Therapy in Adults With CD33 and/or FLT3 Blood Cancers Including AML/MDS

Who this might be right for
AML/MDSCD33 Expressing Hematological MalignanciesFLT3 Expressing Hematological Malignancies
Senti Biosciences 21
Next Page